BRCA1 and xeroderma pigmentosum: Historically, the diagnosis of conditions that involve genomic instability, such as Lynch syndrome or the presence of BRCA1/2 or xeroderma pigmentosum (XP) defects, has involved the use of imaging-based cancer screening at an earlier age and with increased frequency than that appropriate for the general population.